Chronic fatigue syndrome

Handbook of Clinical Neurology

Volumn 106, Issue , 2012, Pages 573-587

  Nater, Urs M ^a   Heim, Christine M ^a   Raison, Charles ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861162557     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52002-9.00034-6     Document Type: Chapter

References (221)

1. Aaron L.A., Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol 2003, 17:563-574.
2. Abbot N.C., Spence V. Chronic fatigue syndrome. Lancet 2006, 367:1574. author reply 1575.
3. Afari N., Schmaling K.B., Herrell R., et al. Coping strategies in twins with chronic fatigue and chronic fatigue syndrome. J Psychosom Res 2000, 48:547-554.
4. Altemus M., Dale J.K., Michelson D., et al. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome. Psychoneuroendocrinology 2001, 26:175-188.
5. Antoni M.H., Brickman A., Lutgendorf S., et al. Psychosocial correlates of illness burden in chronic fatigue syndrome. Clin Infect Dis 1994, 18:S73-S78.
6. Appel S., Chapman J., Shoenfeld Y. Infection and vaccination in chronic fatigue syndrome: myth or reality?. Autoimmunity 2007, 40:48-53.
7. Arnold L.M., Lu Y., Crofford L.J., et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 2004, 50:2974-2984.
8. Arnold L.M., Rosen A., Pritchett Y.L., et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005, 119:5-15.
9. Ax S., Gregg V.H., Jones D. Caring for a relative with chronic fatigue syndrome: difficulties, cognition and acceptance over time. J R Soc Health 2002, 122:35-42.
10. Barsky A.J., Borus J.F. Functional somatic syndromes. Ann Intern Med 1999, 130:910-921.
11. Bates D.W., Schmitt W., Buchwald D., et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993, 153:2759-2765.
12. Bierl C., Nisenbaum R., Hoaglin D.C., et al. Regional distribution of fatiguing illnesses in the United States: a pilot study. Population Health Metrics 2004, 2:1.
13. Blakely A.A., Howard R.C., Sosich R.M., et al. Psychiatric symptoms, personality and ways of coping in chronic fatigue syndrome. Psychol Med 1991, 21:347-362.
14. Borish L., Schmaling K., DiClementi J.D., et al. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables. J Allergy Clin Immunol 1998, 102:222-230.
15. Bou-Holaigah I., Rowe P.C., Kan J., et al. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995, 274:961-967.
16. Bounous G., Molson J. Competition for glutathione precursors between the immune system and the skeletal muscle: pathogenesis of chronic fatigue syndrome. Med Hypotheses 1999, 53:347-349.
17. Briggs N.C., Levine P.H. A comparative review of systemic and neurological symptomatology in 12 outbreaks collectively described as chronic fatigue syndrome, epidemic neuromyasthenia, and myalgic encephalomyelitis. Clin Infect Dis 1994, 18:S32-S42.
18. Buchwald D., Sullivan J.L., Komaroff A.L. Frequency of 'chronic active Epstein-Barr virus infection' in a general medical practice. JAMA 1987, 257:2303-2307.
19. Buchwald D., Cheney P.R., Peterson D.L., et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med 1992, 116:103-113.
20. Buchwald D., Ashley R.L., Pearlman T., et al. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. J Med Virol 1996, 50:25-30.
21. Buchwald D., Pearlman T., Kith P., et al. Screening for psychiatric disorders in chronic fatigue and chronic fatigue syndrome. J Psychosom Res 1997, 42:87-94.
22. Buchwald D., Herrell R., Ashton S., et al. A twin study of chronic fatigue. Psychosom Med 2001, 63:936-943.
23. Buckley L., MacHale S.M., Cavanagh J.T., et al. Personality dimensions in chronic fatigue syndrome and depression. J Psychosom Res 1999, 46:395-400.
24. Cairns V., Godwin J. Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol 2005, 34:1340-1345.
25. Candy B., Chalder T., Cleare A.J., et al. Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med 2003, 33:847-855.
26. Cannon J.G., Angel J.B., Abad L.W., et al. Interleukin-1 beta, interleukin-1 receptor antagonist, and soluble interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol 1997, 17:253-261.
27. Cannon J.G., Angel J.B., Abad L.W., et al. Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome. J Clin Immunol 1998, 18:291-298.
28. Carlo-Stella N., Badulli C., De Silvestri A., et al. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 2006, 24:179-182.
29. Caseras X., Mataix-Cols D., Giampietro V., et al. Probing the working memory system in chronic fatigue syndrome: a functional magnetic resonance imaging study using the n-back task. Psychosom Med 2006, 68:947-955.
30. Cathebras P., Jacquin L., le Gal M., et al. Correlates of somatic causal attributions in primary care patients with fatigue. Psychother Psychosom 1995, 63:174-180.
31. Centers for Disease Control Chronic fatigue possibly related to Epstein-Barr virus-Nevada. MMWR Morb Mortal Wkly Rep 1986, 35:350-352.
32. Cevik R., Gur A., Acar S., et al. Hypothalamic-pituitary-gonadal axis hormones and cortisol in both menstrual phases of women with chronic fatigue syndrome and effect of depressive mood on these hormones. BMC Musculoskelet Disord 2004, 5:47.
33. Chaudhuri A., Behan P.O. Fatigue in neurological disorders. Lancet 2004, 363:978-988.
34. Chia J.K. The role of enterovirus in chronic fatigue syndrome. J Clin Pathol 2005, 58:1126-1132.
35. Christodoulou C., Deluca J., Johnson S.K., et al. Examination of Cloninger's basic dimensions of personality in fatiguing illness: chronic fatigue syndrome and multiple sclerosis. J Psychosom Res 1999, 47:597-607.
36. Clauw D.J., Chrousos G.P. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation 1997, 4:134-153.
37. Cleare A.J., Heap E., Malhi G.S., et al. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999, 353:455-458.
38. Cleare A.J., Blair D., Chambers S., et al. Urinary free cortisol in chronic fatigue syndrome. Am J Psychiatry 2001, 158:641-643.
39. Cleare A.J., Miell J., Heap E., et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 2001, 86:3545-3554.
40. Cleare A.J., Messa C., Rabiner E.A., et al. Brain 5-HT1A receptor binding in chronic fatigue syndrome measured using positron emission tomography and [11C]WAY-100635. Biol Psychiatry 2005, 57:239-246.
41. Clements A., Sharpe M., Simkin S., et al. Chronic fatigue syndrome: a qualitative investigation of patients' beliefs about the illness. J Psychosom Res 1997, 42:615-624.
42. Cook D.B., Lange G., DeLuca J., et al. Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int J Neurosci 2001, 107:1-6.
43. Cope H., Pernet A., Kendall B., et al. Cognitive functioning and magnetic resonance imaging in chronic fatigue. Br J Psychiatry 1995, 167:86-94.
44. Cope H., Mann A., Pelosi A., et al. Psychosocial risk factors for chronic fatigue and chronic fatigue syndrome following presumed viral illness: a case-control study. Psychol Med 1996, 26:1197-1209.
45. Cordero D.L., Sisto S.A., Tapp W.N., et al. Decreased vagal power during treadmill walking in patients with chronic fatigue syndrome. Clin Auton Res 1996, 6:329-333.
46. Costa D.C., Tannock C., Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 1995, 88:767-773.
47. Creswell C., Chalder T. Defensive coping styles in chronic fatigue syndrome. J Psychosom Res 2001, 51:607-610.
48. Creswell C., Chalder T. The relationship between illness attributions and attributional style in chronic fatigue syndrome. Br J Clin Psychol 2003, 42:101-104.
49. Crofford L.J., Young E.A., Engleberg N.C., et al. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome. Brain Behav Immun 2004, 18:314-325.
50. Deale A., Chalder T., Marks I., et al. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial [see comment]. Am. J. Psychiatry 1997, 154:408-414.
51. Deale A., Chalder T., Wessely S. Illness beliefs and treatment outcome in chronic fatigue syndrome. J Psychosom Res 1998, 45:77-83.
52. Deale A., Husain K., Chalder T., et al. Long-term outcome of cognitive behavior therapy versus relaxation therapy for chronic fatigue syndrome: a 5-year follow-up study. Am J Psychiatry 2001, 158:2038-2042.
53. De Becker P., Dendale P., De Meirleir K., et al. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998, 105:22S-26S.
54. de Lange F.P., Kalkman J.S., Bleijenberg G., et al. Neural correlates of the chronic fatigue syndrome - an fMRI study. Brain 2004, 127:1948-1957.
55. de Lange F.P., Kalkman J.S., Bleijenberg G., et al. Gray matter volume reduction in the chronic fatigue syndrome. Neuroimage 2005, 26:777-781.
56. De Lorenzo F., Hargreaves J., Kakkar V.V. Possible relationship between chronic fatigue and postural tachycardia syndromes. Clin Auton Res 1996, 6:263-264.
57. Demitrack M.A., Dale J.K., Straus S.E., et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991, 73:1224-1234.
58. Devanur L.D., Kerr J.R. Chronic fatigue syndrome. J Clin Virol 2006, 37:139-150.
59. Di Giorgio A., Hudson M., Jerjes W., et al. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome. Psychosom Med 2005, 67:433-440.
60. Duprez D.A., De Buyzere M.L., Drieghe B., et al. Long- and short-term blood pressure and RR-interval variability and psychosomatic distress in chronic fatigue syndrome. Clin Sci (Lond) 1998, 94:57-63.
61. Farmer A., Scourfield J., Martin N., et al. Is disabling fatigue in childhood influenced by genes?. Psychol Med 1999, 29:279-282.
62. Findley J.C., Kerns R., Weinberg L.D., et al. Self-efficacy as a psychological moderator of chronic fatigue syndrome. J Behav Med 1998, 21:351-362.
63. Fischler B., D'Haenen H., Cluydts R., et al. Comparison of 99m Tc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology 1996, 34:175-183.
64. Fischler B., Cluydts R., De Gucht Y., et al. Generalized anxiety disorder in chronic fatigue syndrome. Acta Psychiatr Scand 1997, 95:405-413.
65. Freeman R., Komaroff A.L. Does the chronic fatigue syndrome involve the autonomic nervous system?. Am J Med 1997, 102:357-364.
66. Fukuda K., Straus S.E., Hickie I., et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994, 121:953-959.
67. Fulcher K.Y., White P.D. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome [see comment]. BMJ 1997, 314:1647-1652.
68. Gaab J., Huster D., Peisen R., et al. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med 2002, 64:311-318.
69. Gaab J., Huster D., Peisen R., et al. Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects. Psychosomatics 2003, 44:113-119.
70. Gaudino E.A., Coyle P.K., Krupp L.B. Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences. Arch Neurol 1997, 54:1372-1376.
71. Goertzel B.N., Pennachin C., de Souza Coelho L., et al. Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics 2006, 7:475-483.
72. Greco A., Tannock C., Brostoff J., et al. Brain MR in chronic fatigue syndrome. AJNR Am J Neuroradiol 1997, 18:1265-1269.
73. Gur A., Cevik R., Nas K., et al. Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones. Arthritis Res Ther 2004, 6:R232-R238.
74. Hamilos D.L., Nutter D., Gershtenson J., et al. Core body temperature is normal in chronic fatigue syndrome. Biol Psychiatry 1998, 43:293-302.
75. Hatcher S., House A. Life events, difficulties and dilemmas in the onset of chronic fatigue syndrome: a case-control study. Psychol Med 2003, 33:1185-1192.
76. Heijmans M.J. Coping and adaptive outcome in chronic fatigue syndrome: importance of illness cognitions. J Psychosom Res 1998, 45:39-51.
77. Heim C., Bierl C., Nisenbaum R., et al. Regional prevalence of fatiguing illnesses in the United States before and after the terrorist attacks of September 11, 2001. Psychosom Med 2004, 66:672-678.
78. Heim C., Wagner D., Maloney E., et al. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry 2006, 63:1258-1266.
79. Hellinger W.C., Smith T.F., Van Scoy R.E., et al. Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen. JAMA 1988, 260:971-973.
80. Henderson M., Tannock C. Objective assessment of personality disorder in chronic fatigue syndrome. J Psychosom Res 2004, 56:251-254.
81. Hickie I., Bennett B., Lloyd A., et al. Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study. Psychol Med 1999, 29:269-277.
82. Hickie I., Kirk K., Martin N. Unique genetic and environmental determinants of prolonged fatigue: a twin study. Psychol Med 1999, 29:259-268.
83. Holmes G.P., Kaplan J.E., Gantz N.M., et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988, 108:387-389.
84. Hudson M., Cleare A.J. The 1microg short Synacthen test in chronic fatigue syndrome. Clin Endocrinol (Oxf) 1999, 51:625-630.
85. Ichise M., Salit I.E., Abbey S.E., et al. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 1992, 13:767-772.
86. Inder W.J., Prickett T.C., Mulder R.T. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment. Clin Endocrinol (Oxf) 2005, 62:343-348.
87. Jason L.A., Wagner L., Rosenthal S., et al. Estimating the prevalence of chronic fatigue syndrome among nurses. Am J Med 1998, 105:91S-93S.
88. Jason L.A., Richman J.A., Rademaker A.W., et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999, 159:2129-2137.
89. Jason L.A., Witter E., Torres-Harding S. Chronic fatigue syndrome, coping, optimism and social support. J Ment Health 2003, 12:109-118.
90. Jereczek-Fossa B.A., Marsiglia H.R., Orecchia R. Radiotherapy-related fatigue. Crit Rev Oncol Hematol 2002, 41:317-325.
91. Jerjes W.K., Cleare A.J., Wessely S., et al. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome. J Affect Disord 2005, 87:299-304.
92. Jerjes W.K., Peters T.J., Taylor N.F., et al. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome. J Psychosom Res 2006, 60:145-153.
93. Jerjes W.K., Taylor N.F., Peters T.J., et al. Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome. Psychosom Med 2006, 68:578-582.
94. Jerjes W.K., Taylor N.F., Wood P.J., et al. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome. Psychoneuroendocrinology 2007, 32:192-198.
95. Johnson S.K., DeLuca J., Natelson B.H. Personality dimensions in the chronic fatigue syndrome: a comparison with multiple sclerosis and depression. J Psychiatr Res 1996, 30:9-20.
96. Jones J.F., Ray C.G., Minnich L.L., et al. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985, 102:1-7.
97. Jones J.F., Nicholson A., Nisenbaum R., et al. Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med 2005, 118:1415.
98. Kane R.L., Gantz N.M., DiPino R.K. Neuropsychological and psychological functioning in chronic fatigue syndrome. Neuropsychiatry Neuropsychol Behav Neurol 1997, 10:25-31.
99. Kang H.K., Natelson B.H., Mahan C.M., et al. Post-traumatic stress disorder and chronic fatigue syndrome-like illness among Gulf War veterans: a population-based survey of 30,000 veterans. Am J Epidemiol 2003, 157:141-148.
100. Karas B., Grubb B.P., Boehm K., et al. The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. Pacing Clin Electrophysiol 2000, 23:344-351.
101. Kato K., Sullivan P.F., Evengard B., et al. Premorbid predictors of chronic fatigue. Arch Gen Psychiatry 2006, 63:1267-1272.
102. Kaushik N., Fear D., Richards S.C., et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 2005, 58:826-832.
103. Kavelaars A., Kuis W., Knook L., et al. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000, 85:692-696.
104. Knoop H., Prins J.B., Stulemeijer M., et al. The effect of cognitive behaviour therapy for chronic fatigue syndrome on self-reported cognitive impairments and neuropsychological test performance. J Neurol Neurosurg Psychiatry 2007, 78:434-436.
105. Komaroff A.L., Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991, 13:S8-S11.
106. Korszun A., Sackett-Lundeen L., Papadopoulos E., et al. Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 1999, 26:2675-2680.
107. LaManca J.J., Peckerman A., Walker J., et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999, 19:111-120.
108. Lange G., DeLuca J., Maldjian J.A., et al. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci 1999, 171:3-7.
109. Lange G., Holodny A.I., DeLuca J., et al. Quantitative assessment of cerebral ventricular volumes in chronic fatigue syndrome. Appl Neuropsychol 2001, 8:23-30.
110. Lange G., Steffener J., Cook D.B., et al. Objective evidence of cognitive complaints in chronic fatigue syndrome: a BOLD fMRI study of verbal working memory. Neuroimage 2005, 26:513-524.
111. Lehman A.M., Lehman D.R., Hemphill K.J., et al. Illness experience, depression, and anxiety in chronic fatigue syndrome. J Psychosom Res 2002, 52:461-465.
112. Leone S.S., Huibers M.J., Kant I., et al. Long-term efficacy of cognitive-behavioral therapy by general practitioners for fatigue: a 4-year follow-up study. J Psychosom Res 2006, 61:601-607.
113. Lewis D.H., Mayberg H.S., Fischer M.E., et al. Monozygotic twins discordant for chronic fatigue syndrome: regional cerebral blood flow SPECT. Radiology 2001, 219:766-773.
114. Lutgendorf S.K., Antoni M.H., Ironson G., et al. Physical symptoms of chronic fatigue syndrome are exacerbated by the stress of Hurricane Andrew. Psychosom Med 1995, 57:310-323.
115. Lyall M., Peakman M., Wessely S. A systematic review and critical evaluation of the immunology of chronic fatigue syndrome. J Psychosom Res 2003, 55:79-90.
116. MacHale S.M., Cavanagh J.T., Bennie J., et al. Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 1998, 38:213-217.
117. MacHale S.M., Lawrie S.M., Cavanagh J.T., et al. Cerebral perfusion in chronic fatigue syndrome and depression. Br J Psychiatry 2000, 176:550-556.
118. Magnusson A.E., Nias D.K., White P.D. Is perfectionism associated with fatigue?. J Psychosom Res 1996, 41:377-383.
119. Masuda A., Munemoto T., Yamanaka T., et al. Psychosocial characteristics and immunological functions in patients with postinfectious chronic fatigue syndrome and noninfectious chronic fatigue syndrome. J Behav Med 2002, 25:477-485.
120. Mawle A.C., Nisenbaum R., Dobbins J.G., et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis 1997, 175:136-141.
121. McCauley J., Kern D.E., Kolodner K., et al. Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA 1997, 277:1362-1368.
122. McCauley L.A., Joos S.K., Barkhuizen A., et al. Chronic fatigue in a population-based study of Gulf War veterans. Arch Environ Health 2002, 57:340-348.
123. Minderhoud I.M., Oldenburg B., van Dam P.S., et al. High prevalence of fatigue in quiescent inflammatory bowel disease is not related to adrenocortical insufficiency. Am J Gastroenterol 2003, 98:1088-1093.
124. Montague T.J., Marrie T.J., Klassen G.A., et al. Cardiac function at rest and with exercise in the chronic fatigue syndrome. Chest 1989, 95:779-784.
125. Montgomery G.K. Uncommon tiredness among college undergraduates. J Consult Clin Psychol 1983, 51:517-525.
126. Narita M., Nishigami N., Narita N., et al. Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun 2003, 311:264-266.
127. Naschitz J.E., Rozenbaum M., Rosner I., et al. Cardiovascular response to upright tilt in fibromyalgia differs from that in chronic fatigue syndrome. J Rheumatol 2001, 28:1356-1360.
128. Natelson B.H., Cohen J.M., Brassloff I., et al. A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J Neurol Sci 1993, 120:213-217.
129. Natelson B.H., Cheu J., Pareja J., et al. Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome. Psychopharmacology 1996, 124:226-230.
130. Nater U.M., Wagner D., Solomon L., et al. Coping styles in people with chronic fatigue syndrome identified from the general population of Wichita, KS. J Psychosom Res 2006, 60:567-573.
131. Nater U.M., Youngblood L.S., Jones J.F., et al. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med 2008, 70:298-305.
132. Okada T., Tanaka M., Kuratsune H., et al. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol 2004, 4:14.
133. Pagani M., Lucini D., Mela G.S., et al. Sympathetic overactivity in subjects complaining of unexplained fatigue. Clin Sci (Lond) 1994, 87:655-661.
134. Patarca R. Cytokines and chronic fatigue syndrome. Ann N Y Acad Sci 2001, 933:185-200.
135. Patarca-Montero R., Antoni M., Fletcher M.A., et al. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol 2001, 8:51-64.
136. Peterson P.K., Sirr S.A., Grammith F.C., et al. Effects of mild exercise on cytokines and cerebral blood flow in chronic fatigue syndrome patients. Clin Diagn Lab Immunol 1994, 1:222-226.
137. Piche T., Huet P.M., Gelsi E., et al. Fatigue in irritable bowel syndrome: characterization and putative role of leptin. Eur J Gastroenterol Hepatol 2007, 19:237-243.
138. Poole J., Herrell R., Ashton S., et al. Results of isoproterenol tilt table testing in monozygotic twins discordant for chronic fatigue syndrome. Arch Intern Med 2000, 160:3461-3468.
139. Poteliakhoff A. Adrenocortical activity and some clinical findings in acute and chronic fatigue. J Psychosom Res 1981, 25:91-95.
140. Powell P., Bentall R.P., Nye F.J., et al. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome [see comment]. BMJ 2001, 322:387-390.
141. Powell R., Ren J., Lewith G., et al. Identification of novel expressed sequences, up-regulated in the leucocytes of chronic fatigue syndrome patients. Clin Exp Allergy 2003, 33:1450-1456.
142. Powell P., Bentall R.P., Nye F.J., et al. Patient education to encourage graded exercise in chronic fatigue syndrome. 2-year follow-up of randomised controlled trial. Br J. Psychiatry 2004, 184:142-146.
143. Price R.K., North C.S., Wessely S., et al. Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep 1992, 107:514-522.
144. Prins J.B., Bleijenberg G., Bazelmans E., et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial.[see comment]. Lancet 2001, 357:841-847.
145. Racciatti D., Guagnano M.T., Vecchiet J., et al. Chronic fatigue syndrome: circadian rhythm and hypothalamic-pituitary-adrenal (HPA) axis impairment. Int J Immunopathol Pharmacol 2001, 14:11-15.
146. Rajeevan M.S., Smith A.K., Dimulescu I., et al. Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome. Genes Brain Behav 2007, 6:167-176.
147. Reeves W.C., Lloyd A., Vernon S.D., et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res 2003, 3:25.
148. Reeves W.C., Wagner D., Nisenbaum R., et al. Chronic fatigue syndrome - a clinically empirical approach to its definition and study. BMC Med 2005, 3:19.
149. Reeves W.C., Jones J.F., Maloney E., et al. Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia. Population Health Metrics 2007, 5:5.
150. Reuter K., Harter M. The concepts of fatigue and depression in cancer. Eur J Cancer Care (Engl) 2004, 13:127-134.
151. Reyes M., Dobbins J.G., Mawle A.C., et al. Risk factors for CFS: a case control study. Journal of Chronic Fatigue Syndrome 1996, 2:17-33.
152. Reyes M., Gary H.E., Dobbins J.G., et al. Surveillance for chronic fatigue syndrome - four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ 1997, 46:1-13.
153. Reyes M., Nisenbaum R., Hoaglin D.C., et al. Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med 2003, 163:1530-1536.
154. Ridsdale L., Darbishire L., Seed P.T. Is graded exercise better than cognitive behaviour therapy for fatigue? A UK randomized trial in primary care. Psychol Med 2004, 34:37-49.
155. Rimes K.A., Chalder T. Treatments for chronic fatigue syndrome. Occup Med (Oxf) 2005, 55:32-39.
156. Roberts A.D., Wessely S., Chalder T., et al. Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry 2004, 184:136-141.
157. Romans S., Belaise C., Martin J., et al. Childhood abuse and later medical disorders in women. An epidemiological study. Psychother Psychosom 2002, 71:141-150.
158. Rowe P.C., Bou-Holaigah I., Kan J.S., et al. Is neurally mediated hypotension an unrecognised cause of chronic fatigue?. Lancet 1995, 345:623-624.
159. Rowe P.C., Calkins H., DeBusk K., et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 2001, 285:52-59.
160. Salit I.E. Precipitating factors for the chronic fatigue syndrome. J Psychiatr Res 1997, 31:59-65.
161. Schmaling K.B., Lewis D.H., Fiedelak J.I., et al. Single-photon emission computerized tomography and neurocognitive function in patients with chronic fatigue syndrome. Psychosom Med 2003, 65:129-136.
162. Schondorf R., Benoit J., Wein T., et al. Orthostatic intolerance in the chronic fatigue syndrome. J Auton Nerv Syst 1999, 75:192-201.
163. Schwartz R.B., Komaroff A.L., Garada B.M., et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. AJR Am J Roentgenol 1994, 162:943-951.
164. Scott L.V., Dinan T.G. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord 1998, 47:49-54.
165. Scott L.V., Medbak S., Dinan T.G. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998, 97:450-457.
166. Scott L.V., Medbak S., Dinan T.G. The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol (Oxf) 1998, 48:733-737.
167. Segal T.Y., Hindmarsh P.C., Viner R.M. Disturbed adrenal function in adolescents with chronic fatigue syndrome. J Pediatr Endocrinol Metab 2005, 18:295-301.
168. Sharpe M., Hawton K., Simkin S., et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial [see comment]. BMJ 1996, 312:22-26.
169. Siessmeier T., Nix W.A., Hardt J., et al. Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 2003, 74:922-928.
170. Siniscalchi M., Iovino P., Tortora R., et al. Fatigue in adult coeliac disease. Aliment Pharmacol Ther 2005, 22:489-494.
171. Sisto S.A., Tapp W., Drastal S., et al. Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome. Clin Auton Res 1995, 5:139-143.
172. Skapinakis P., Lewis G., Mavreas V. Unexplained fatigue syndromes in a multinational primary care sample: specificity of definition and prevalence and distinctiveness from depression and generalized anxiety. Am J Psychiatry 2003, 160:785-787.
173. Skapinakis P., Lewis G., Meltzer H. Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain. Int Rev Psychiatry 2003, 15:57-64.
174. Skowera A., Cleare A., Blair D., et al. High levels of type 2 cytokine-producing cells in chronic fatigue syndrome. Clin Exp Immunol 2004, 135:294-302.
175. Smith A.K., White P.D., Aslakson E., et al. Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 2006, 7:387-394.
176. Soetekouw P.M., Lenders J.W., Bleijenberg G., et al. Autonomic function in patients with chronic fatigue syndrome. Clin Auton Res 1999, 9:334-340.
177. Soto N.E., Straus S.E. Chronic fatigue syndrome and herpesviruses: the fading evidence. Herpes 2000, 7:46-50.
178. Steele L., Dobbins J.G., Fukuda K., et al. The epidemiology of chronic fatigue in San Francisco. Am J Med 1998, 105:83S-90S.
179. Steinau M., Unger E.R., Vernon S.D., et al. Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome. J Mol Med 2004, 82:750-755.
180. Stewart J.M. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res 2000, 48:218-226.
181. Stewart J., Weldon A., Arlievsky N., et al. Neurally mediated hypotension and autonomic dysfunction measured by heart rate variability during head-up tilt testing in children with chronic fatigue syndrome. Clin Auton Res 1998, 8:221-230.
182. Stewart J.M., Gewitz M.H., Weldon A., et al. Patterns of orthostatic intolerance: the orthostatic tachycardia syndrome and adolescent chronic fatigue. J Pediatr 1999, 135:218-225.
183. Straus S.E. History of chronic fatigue syndrome. Rev Infect Dis 1991, 13:S2-S7.
184. Straus S.E., Tosato G., Armstrong G., et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985, 102:7-16.
185. Straus S.E., Dale J.K., Peter J.B., et al. Circulating lymphokine levels in the chronic fatigue syndrome. J Infect Dis 1989, 160:1085-1086.
186. Streeten D.H., Thomas D., Bell D.S. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2000, 320:1-8.
187. Strickland P., Morriss R., Wearden A., et al. A comparison of salivary cortisol in chronic fatigue syndrome, community depression and healthy controls. J Affect Disord 1998, 47:191-194.
188. Sullivan P.F., Evengard B., Jacks A., et al. Twin analyses of chronic fatigue in a Swedish national sample. Psychol Med 2005, 35:1327-1336.
189. Sundbom E., Henningsson M., Holm U., et al. Possible influence of defenses and negative life events on patients with chronic fatigue syndrome: a pilot study. Psychol Rep 2002, 91:963-978.
190. Surawy C., Hackmann A., Hawton K., et al. Chronic fatigue syndrome: a cognitive approach. Behav Res Ther 1995, 33:535-544.
191. Taillefer S.S., Kirmayer L.J., Robbins J.M., et al. Correlates of illness worry in chronic fatigue syndrome. J Psychosom Res 2003, 54:331-337.
192. Tanaka H., Matsushima R., Tamai H., et al. Impaired postural cerebral hemodynamics in young patients with chronic fatigue with and without orthostatic intolerance. J Pediatr 2002, 140:412-417.
193. Tanaka M., Sadato N., Okada T., et al. Reduced responsiveness is an essential feature of chronic fatigue syndrome: a fMRI study. BMC Neurol 2006, 6:9.
194. Tavio M., Milan I., Tirelli U. Cancer-related fatigue (review). Int J Oncol 2002, 21:1093-1099.
195. Theorell T., Blomkvist V., Lindh G., et al. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med 1999, 61:304-310.
196. Thomas M.A., Smith A.P. Primary healthcare provision and chronic fatigue syndrome: a survey of patients' and general practitioners' beliefs. BMC Fam Pract 2005, 6:49.
197. Tirelli U., Chierichetti F., Tavio M., et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998, 105:54S-58S.
198. Torpy D.J., Bachmann A.W., Gartside M., et al. Association between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SER224 polymorphism. Endocr Res 2004, 30:417-429.
199. van de Luit L., van der Meulen J., Cleophas T.J., et al. Amplified amplitudes of circadian rhythms and nighttime hypotension in patients with chronic fatigue syndrome: improvement by inopamil but not by melatonin. Angiology 1998, 49:903-908.
200. van Geelen S.M., Sinnema G., Hermans H.J., et al. Personality and chronic fatigue syndrome: methodological and conceptual issues. Clin Psychol Rev 2007, 27:885-903.
201. Van Houdenhove B., Neerinckx E., Lysens R., et al. Victimization in chronic fatigue syndrome and fibromyalgia in tertiary care: a controlled study on prevalence and characteristics. Psychosomatics 2001, 42:21-28.
202. van Tubergen A., Coenen J., Landewe R., et al. Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis. Arthritis Rheum 2002, 47:8-16.
203. Vercoulen J.H., Swanink C.M., Zitman F.G., et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996, 347:858-861.
204. Vladutiu G.D., Natelson B.H. Association of medically unexplained fatigue with ACE insertion/deletion polymorphism in Gulf War veterans. Muscle Nerve 2004, 30:38-43.
205. von Mikecz A., Konstantinov K., Buchwald D.S., et al. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum 1997, 40:295-305.
206. Wallace H.L., Natelson B., Gause W., et al. Human herpesviruses in chronic fatigue syndrome. Clin Diagn Lab Immunol 1999, 6:216-223.
207. Wallman K.E., Morton A.R., Goodman C., et al. Randomised controlled trial of graded exercise in chronic fatigue syndrome [see comment]. Med J Aust 2004, 180:444-448.
208. Walsh C.M., Zainal N.Z., Middleton S.J., et al. A family history study of chronic fatigue syndrome. Psychiatr Genet 2001, 11:123-128.
209. Wearden A.J., Morriss R.K., Mullis R., et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome [see comment] [erratum appears in Br J Psychiatry 1998; 173: 89. Br J Psychiatry 1998, 172:485-490.
210. Wessely S., Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med 2002, 32:1-10.
211. Wessely S., White P.D. There is only one functional somatic syndrome. Br J Psychiatry 2004, 185:95-96.
212. Wessely S., Chalder T., Hirsch S., et al. Psychological symptoms, somatic symptoms, and psychiatric disorder in chronic fatigue and chronic fatigue syndrome: a prospective study in the primary care setting. Am J Psychiatry 1996, 153:1050-1059.
213. Wessely S., Nimnuan C., Sharpe M. Functional somatic syndromes: one or many?. Lancet 1999, 354:936-939.
214. Whitehead W.E., Palsson O., Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 2002, 122:1140-1156.
215. Whiteside T.L., Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998, 105:27S-34S.
216. Whiting P., Bagnall A.M., Sowden A.J., et al. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review [see comment] [erratum appears in JAMA 2002; 287: 1401. JAMA 2001, 286:1360-1368.
217. Winkler A.S., Blair D., Marsden J.T., et al. Autonomic function and serum erythropoietin levels in chronic fatigue syndrome. J Psychosom Res 2004, 56:179-183.
218. Wolfe F. Fibromyalgia. Rheum Dis Clin North Am 1990, 16:681-698.
219. Wood B., Wessely S. Personality and social attitudes in chronic fatigue syndrome. J Psychosom Res 1999, 47:385-397.
220. Yataco A., Talo H., Rowe P., et al. Comparison of heart rate variability in patients with chronic fatigue syndrome and controls. Clin Auton Res 1997, 7:293-297.
221. Young A.H., Sharpe M., Clements A., et al. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol Psychiatry 1998, 43:236-237.